We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$345M
AUM Growth
-$28.9M
Cap. Flow
-$37.9M
Cap. Flow %
-10.97%
Top 10 Hldgs %
29.4%
Holding
780
New
93
Increased
153
Reduced
203
Closed
29

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.68%
2 Technology 13.28%
3 Healthcare 12.33%
4 Financials 8.86%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
376
Palo Alto Networks
PANW
$310B
$46K 0.01%
1,128
+1,032
+1,075% +$42.9K
TCDA
377
DELISTED
Tricida, Inc. Common Stock
TCDA
$46K 0.01%
5,075
+1,695
+50% +$24.8K
AVDL
378
DELISTED
Avadel Pharmaceuticals
AVDL
$44.9K 0.01%
8,900
ENS icon
379
EnerSys
ENS
$6.22B
$44.4K 0.01%
662
ALLY icon
380
Ally Financial
ALLY
$12.5B
$44.3K 0.01%
1,766
UAA icon
381
Under Armour
UAA
$2.19B
$42.3K 0.01%
3,767
-5,155
-58% -$54.3K
LTHM
382
DELISTED
Livent Corporation
LTHM
$41.6K 0.01%
4,640
+4,408
+1,900% +$33.2K
BDSI
383
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$40.7K 0.01%
10,923
+5,563
+104% +$23.7K
ARNA
384
DELISTED
Arena Pharmaceuticals Inc
ARNA
$40K 0.01%
535
AMRN
385
Amarin Corp
AMRN
$295M
$39.6K 0.01%
470
-16
-3% -$1.92K
PXD
386
DELISTED
Pioneer Natural Resource Co.
PXD
$39.6K 0.01%
460
PRVL
387
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$37.7K 0.01%
+3,700
New +$49.6K
ECHO
388
EchoStar
ECHO
$27.5B
$37.2K 0.01%
1,494
NOK icon
389
Nokia
NOK
$57B
$37K 0.01%
9,468
KALA icon
390
KALA BIO
KALA
$10.2M
$36.5K 0.01%
2
+1
+100% +$23K
TRQ
391
DELISTED
Turquoise Hill Resources Ltd
TRQ
$36.1K 0.01%
4,277
BUD icon
392
AB InBev
BUD
$157B
$35K 0.01%
650
ALC icon
393
CALL
Alcon
ALC
$32.5B
$34.8K 0.01%
1,268
+12
+1% +$706
ALL icon
394
Allstate
ALL
$64.7B
$34.5K 0.01%
367
LOGI icon
395
CALL
Logitech
LOGI
$14.4B
$34K 0.01%
28
-96
-77% -$6.86K
USAS
396
Americas Gold and Silver
USAS
$1.57B
$33.8K 0.01%
5,160
CI icon
397
Cigna
CI
$75.2B
$33.2K 0.01%
196
-478
-71% -$84.1K
BBWI icon
398
Bath & Body Works
BBWI
$3.48B
$30.5K 0.01%
1,188
ADI icon
399
Analog Devices
ADI
$177B
$30.1K 0.01%
258
-810
-76% -$94.8K
PCG icon
400
PG&E
PCG
$29.4B
$29.8K 0.01%
3,172
+1,677
+112% +$15.5K

Similar funds

Exane Derivatives's Q3 2020 Portfolio in Review

As of Q3 2020, Exane Derivatives held 780 positions worth $345M, down 7.7% from $374M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Exane Derivatives withdrew a net $37.9M in Q3 2020, closing 29 positions and reducing 203 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in iShares MSCI Turkey ETF worth $10.6M.

  • Exane Derivatives's largest Q3 2020 buy was iShares MSCI Turkey ETF: 537,062 shares worth $10.6M.
  • Exane Derivatives added most to State Street Energy Select Sector SPDR ETF in Q3 2020, an estimated $15.1M increase.
  • Exane Derivatives's biggest Q3 2020 reduction was Linde, cutting an estimated $7.17M.
  • Exane Derivatives fully exited iShares MSCI Emerging Markets ETF in Q3 2020, selling an estimated $8.3M.
  • Exane Derivatives's ten largest holdings make up 29% of its $345M portfolio in Q3 2020.
  • Exane Derivatives opened 93 new positions and closed 29 in Q3 2020.
  • Exane Derivatives's portfolio value fell 7.7% quarter-over-quarter to $345M.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.